atazanavir sulfate

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 229975-97-7

Where It Comes From

20 FDA-registered drug labelers
Ardena US, LLC
Aurobindo Pharma Limited
Camber Pharmaceuticals, Inc.
Catalent Pharma Solutions, LLC
Chromo Laboratories India Private Limited
Cipla Ltd.
E.R. Squibb & Sons, L.L.C.
Emcure Pharmaceuticals Limited
Granules India Ltd
Hetero Labs Limited
Honour Lab Limited
Laurus Labs Limited
Matrix Pharmacorp Private Limited
MSN Pharmachem Private Limited
Olon S.p.A.
Patheon Inc.
SciAnda(Changshu) Pharmaceuticals, Ltd.
Siegfried St. Vulbas SAS
SK BIOTEK IRELAND LIMITED
Teva Pharmaceuticals USA, Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 4 drug and cosmetic product listings (FDA).

  • Atazanavir
  • Atazanavir Sulfate
  • Reyataz
  • Evotaz
FDA Shortage Status
No Shortage
Shortage History
to be discontinued

Atazanavir Sulfate Oral Powder

06/04/2025

to be discontinued

Atazanavir Sulfate Capsule

06/04/2025

to be discontinued

Atazanavir Sulfate; Cobicistat Tablet

11/03/2025

Chemical Identity

CAS229975-97-7
PubChem CID158550
DTXSIDDTXSID401017206
FormulaC38H54N6O11S
Mol. Weight802.9 g/mol
SMILESCC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O

Data Sources

1585502026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/atazanavir sulfate/cids/JSON

Archive: data/sources/pubchem_name/atazanavir sulfate.json

CAS 229975-97-72026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

CAS 229975-97-72026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json